Hostname: page-component-77f85d65b8-5ngxj Total loading time: 0 Render date: 2026-03-26T23:04:10.845Z Has data issue: false hasContentIssue false

Executive Function in Children and Adolescents with Critical Cyanotic Congenital Heart Disease

Published online by Cambridge University Press:  09 December 2014

Adam R. Cassidy*
Affiliation:
Department of Psychiatry, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts
Matthew T. White
Affiliation:
Department of Psychiatry, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts
David R. DeMaso
Affiliation:
Department of Psychiatry, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts
Jane W. Newburger
Affiliation:
Department of Cardiology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts
David C. Bellinger
Affiliation:
Department of Psychiatry, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts Department of Neurology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts
*
Correspondence and reprint requests to: Adam R. Cassidy, Center for Neuropsychology, Department of Psychiatry, Boston Children’s Hospital, Boston, MA 02115. E-mail: adam.cassidy@childrens.harvard.edu
Rights & Permissions [Opens in a new window]

Abstract

Children and adolescents with critical cyanotic congenital heart disease (CHD) are at risk for deficits in aspects of executive function (EF). The primary aim of this investigation was to compare EF outcomes in three groups of children/adolescents with severe CHD and controls (ages 10–19 years). Participants included 463 children/adolescents with CHD [dextro-transposition of the great arteries (TGA), n=139; tetralogy of Fallot (TOF), n=68; and, single-ventricle anatomy requiring Fontan procedure (SVF), n=145] and 111 controls, who underwent laboratory and informant-based evaluation of EF skills. Rates of EF impairment on D-KEFS measures were nearly twice as high for CHD groups (75–81%) than controls (43%). Distinct EF profiles were documented between CHD groups on D-KEFS tasks. Deficits in flexibility/problem-solving and verbally mediated EF skills were documented in all three CHD groups; visuo-spatially mediated EF abilities were impaired in TOF and SVF groups, but preserved in TGA. Parent, teacher, and self-report ratings on the BRIEF highlighted unique patterns of metacognitive and self-regulatory concerns across informants. CHD poses a serious threat to EF development. Greater severity of CHD is associated with worse EF outcomes. With increased understanding of the cognitive and self-regulatory vulnerabilities experienced by children and adolescents with CHD, it may be possible to identify risks early and provide individualized supports to promote optimal neurodevelopment. (JINS, 2014, 20, 34–49)

Information

Type
Research Articles
Copyright
Copyright © The International Neuropsychological Society 2014 
Figure 0

Table 1 Sample demographic characteristics by cardiac diagnosis

Figure 1

Fig. 1 Estimated marginal means of D-KEFS tasks in cardiac and control groups, controlling for SES, age, sex, and race (error bars represent 95% confidence intervals). TGA=dextro-transposition of the great arteries; TOF=tetralogy of Fallot; SVF=single-ventricle children/adolescents who underwent the Fontan procedure; VFL=Verbal Fluency; TCC=Total Consecutively Correct; CCS=Confirmed Correct Sorts; DFL=Design Fluency; TAS=Total Achievement Score; TPMR=Time per Move Ratio; MAR=Move-Accuracy Ratio.

Figure 2

Table 2 D-KEFS subtest performance and impaired subtest score percentages by cardiac diagnosis

Figure 3

Table 3 Odds of impairment on D-KEFS subtest by CHD group as compared to controls

Figure 4

Table 4 BRIEF descriptive results and elevated subscale score percentages by CHD diagnosis

Figure 5

Table 5 Odds of clinically significant problems on BRIEF subscale by CHD group as compared to controls

Figure 6

Table 6 Paired t-test results comparing BRIEF self-report vs. parent/teacher ratings

Figure 7

Table 7 Correlations between D-KEFS and BRIEF variables for CHD and control groups